Abstract
This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19 in immunocompromised patients, including persons with human immunodeficiency virus. It describes various preventive measures, including vaccines and their effectiveness and the role of monoclonal antibodies for pre-exposure prophylaxis. It also reviews the different treatment options for immunocompromised individuals, including antivirals, monoclonal antibodies, and immunomodulators. Lastly, it describes the impact of COVID-19 on transplantation and continuity care of this population.
Keywords: CD4; COVID-19; HIV; Hematopoietic stem cell transplant; Immunocompromise; Immunosuppression; SARS-CoV-2; Solid organ transplant.
【저자키워드】 COVID-19, SARS-CoV-2, HIV, Immunosuppression, CD4, solid organ transplant., Hematopoietic stem cell transplant, Immunocompromise, 【초록키워드】 Treatment, Vaccine, Mortality, Epidemiology, antivirals, monoclonal antibody, Immunocompromised patients, risk factor, monoclonal antibodies, Prophylaxis, immunomodulators, Effectiveness, preventive measures, incidence, Hematopoietic stem cell, Human immunodeficiency virus, Care, solid organ, immunocompromised individuals, 【제목키워드】 Human, Including,